Royal's branded division will augment Granard’s trade and distribution services as well as their generic products group. Royal Pharmaceuticals is currently seeking branded pharmaceuticals to in-license or purchase.“Having presence in both pharmaceutical services and generics, the next logical step in diversifying our portfolio is marketing branded products under Royal Pharmaceuticals,” said Armand Crupi, Executive Vice President.A privately held company for over 15 years, Granard provides trade, sales, and marketing representation to both brand and generic pharmaceutical companies. Granard also provides manufacturers the opportunity to utilize the brand and generic relationships built over time with chains, wholesalers, distributors and mail order customers. Clients achieve rapid market penetration by Granard leveraging established relationships with more than 80 national points of distribution, including pharmaceutical wholesalers, generic distributors, retail chains and mail order pharmacies.
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment